Clinical trial
A Phase III Study of the Efficacy and Safety of 3APS in Patients With Mild to Moderate Alzheimer's Disease
NCT00088673 is registered in ClinicalTrials.gov with Bellus Health Inc. - a GSK company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Study of the Efficacy and Safety of 3APS in Patients With Mild to Moderate Alzheimer's Disease
- Lead sponsor
- Bellus Health Inc. - a GSK company
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2004
- Completion date
- Not reported
- Enrollment
- 950
- Sites
- 67
Conditions
As the registry lists them; a condition with its own page is linked.